Cargando…

Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador

The Omicron variant of SARS-CoV-2 is the latest pandemic lineage causing COVID-19. Despite having a vaccination rate ≥85%, Ecuador recorded a high incidence of Omicron from December 2021 to March 2022. Since Omicron emerged, it has evolved into multiple sub-lineages with distinct prevalence in diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrazco-Montalvo, Andrés, Herrera-Yela, Andrés, Alarcón-Vallejo, Damaris, Gutiérrez-Pallo, Diana, Armendáriz-Castillo, Isaac, Andrade-Molina, Derly, Muñoz-Mawyin, Karen, Fernández-Cadena, Juan Carlos, Morey-León, Gabriel, Patiño, Leandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230377/
https://www.ncbi.nlm.nih.gov/pubmed/35746651
http://dx.doi.org/10.3390/v14061177
_version_ 1784735042723905536
author Carrazco-Montalvo, Andrés
Herrera-Yela, Andrés
Alarcón-Vallejo, Damaris
Gutiérrez-Pallo, Diana
Armendáriz-Castillo, Isaac
Andrade-Molina, Derly
Muñoz-Mawyin, Karen
Fernández-Cadena, Juan Carlos
Morey-León, Gabriel
Patiño, Leandro
author_facet Carrazco-Montalvo, Andrés
Herrera-Yela, Andrés
Alarcón-Vallejo, Damaris
Gutiérrez-Pallo, Diana
Armendáriz-Castillo, Isaac
Andrade-Molina, Derly
Muñoz-Mawyin, Karen
Fernández-Cadena, Juan Carlos
Morey-León, Gabriel
Patiño, Leandro
author_sort Carrazco-Montalvo, Andrés
collection PubMed
description The Omicron variant of SARS-CoV-2 is the latest pandemic lineage causing COVID-19. Despite having a vaccination rate ≥85%, Ecuador recorded a high incidence of Omicron from December 2021 to March 2022. Since Omicron emerged, it has evolved into multiple sub-lineages with distinct prevalence in different regions. In this work, we use all Omicron sequences from Ecuador available at GISAID until March 2022 and the software Nextclade and Pangolin to identify which lineages circulate in this country. We detected 12 different sub-lineages (BA.1, BA.1.1, BA.1.1.1, BA.1.1.14, BA.1.1.2, BA.1.14, BA.1.15, BA.1.16, BA.1.17, BA.1.6, BA.2, BA.2.3), which have been reported in Africa, America, Europe, and Asia, suggesting multiple introduction events. Sub-lineages BA.1 and BA.1.1 were the most prevalent. Genomic surveillance must continue to evaluate the dynamics of current sub-lineages, the early introduction of new ones and vaccine efficacy against evolving SARS-CoV-2.
format Online
Article
Text
id pubmed-9230377
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92303772022-06-25 Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador Carrazco-Montalvo, Andrés Herrera-Yela, Andrés Alarcón-Vallejo, Damaris Gutiérrez-Pallo, Diana Armendáriz-Castillo, Isaac Andrade-Molina, Derly Muñoz-Mawyin, Karen Fernández-Cadena, Juan Carlos Morey-León, Gabriel Patiño, Leandro Viruses Communication The Omicron variant of SARS-CoV-2 is the latest pandemic lineage causing COVID-19. Despite having a vaccination rate ≥85%, Ecuador recorded a high incidence of Omicron from December 2021 to March 2022. Since Omicron emerged, it has evolved into multiple sub-lineages with distinct prevalence in different regions. In this work, we use all Omicron sequences from Ecuador available at GISAID until March 2022 and the software Nextclade and Pangolin to identify which lineages circulate in this country. We detected 12 different sub-lineages (BA.1, BA.1.1, BA.1.1.1, BA.1.1.14, BA.1.1.2, BA.1.14, BA.1.15, BA.1.16, BA.1.17, BA.1.6, BA.2, BA.2.3), which have been reported in Africa, America, Europe, and Asia, suggesting multiple introduction events. Sub-lineages BA.1 and BA.1.1 were the most prevalent. Genomic surveillance must continue to evaluate the dynamics of current sub-lineages, the early introduction of new ones and vaccine efficacy against evolving SARS-CoV-2. MDPI 2022-05-28 /pmc/articles/PMC9230377/ /pubmed/35746651 http://dx.doi.org/10.3390/v14061177 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Carrazco-Montalvo, Andrés
Herrera-Yela, Andrés
Alarcón-Vallejo, Damaris
Gutiérrez-Pallo, Diana
Armendáriz-Castillo, Isaac
Andrade-Molina, Derly
Muñoz-Mawyin, Karen
Fernández-Cadena, Juan Carlos
Morey-León, Gabriel
Patiño, Leandro
Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
title Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
title_full Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
title_fullStr Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
title_full_unstemmed Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
title_short Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
title_sort omicron sub-lineages (ba.1.1.529 + ba.*) current status in ecuador
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230377/
https://www.ncbi.nlm.nih.gov/pubmed/35746651
http://dx.doi.org/10.3390/v14061177
work_keys_str_mv AT carrazcomontalvoandres omicronsublineagesba11529bacurrentstatusinecuador
AT herrerayelaandres omicronsublineagesba11529bacurrentstatusinecuador
AT alarconvallejodamaris omicronsublineagesba11529bacurrentstatusinecuador
AT gutierrezpallodiana omicronsublineagesba11529bacurrentstatusinecuador
AT armendarizcastilloisaac omicronsublineagesba11529bacurrentstatusinecuador
AT andrademolinaderly omicronsublineagesba11529bacurrentstatusinecuador
AT munozmawyinkaren omicronsublineagesba11529bacurrentstatusinecuador
AT fernandezcadenajuancarlos omicronsublineagesba11529bacurrentstatusinecuador
AT moreyleongabriel omicronsublineagesba11529bacurrentstatusinecuador
AT omicronsublineagesba11529bacurrentstatusinecuador
AT omicronsublineagesba11529bacurrentstatusinecuador
AT patinoleandro omicronsublineagesba11529bacurrentstatusinecuador